351 related articles for article (PubMed ID: 35710426)
21. A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration.
Bahadur S; Prakash A
Curr Drug Targets; 2023; 24(1):71-88. PubMed ID: 36278468
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
Zhao YZ; Lu CT; Li XK; Cai J
Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.
Arsiwala TA; Sprowls SA; Blethen KE; Adkins CE; Saralkar PA; Fladeland RA; Pentz W; Gabriele A; Kielkowski B; Mehta RI; Wang P; Carpenter JS; Ranjan M; Najib U; Rezai AR; Lockman PR
Neoplasia; 2021 Jul; 23(7):676-691. PubMed ID: 34139452
[TBL] [Abstract][Full Text] [Related]
24. Patented nanomedicines for the treatment of brain tumors.
Caruso G; Raudino G; Caffo M
Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.
Kooiman K; Roovers S; Langeveld SAG; Kleven RT; Dewitte H; O'Reilly MA; Escoffre JM; Bouakaz A; Verweij MD; Hynynen K; Lentacker I; Stride E; Holland CK
Ultrasound Med Biol; 2020 Jun; 46(6):1296-1325. PubMed ID: 32165014
[TBL] [Abstract][Full Text] [Related]
26. Submicron-bubble-enhanced focused ultrasound for blood-brain barrier disruption and improved CNS drug delivery.
Fan CH; Liu HL; Ting CY; Lee YH; Huang CY; Ma YJ; Wei KC; Yen TC; Yeh CK
PLoS One; 2014; 9(5):e96327. PubMed ID: 24788566
[TBL] [Abstract][Full Text] [Related]
27. Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound.
Anastasiadis P; Gandhi D; Guo Y; Ahmed AK; Bentzen SM; Arvanitis C; Woodworth GF
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34504017
[TBL] [Abstract][Full Text] [Related]
28. The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure.
Chen H; Konofagou EE
J Cereb Blood Flow Metab; 2014 Jul; 34(7):1197-204. PubMed ID: 24780905
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
[TBL] [Abstract][Full Text] [Related]
30. Focused Ultrasound-Induced Blood-Brain Barrier Opening: Association with Mechanical Index and Cavitation Index Analyzed by Dynamic Contrast-Enhanced Magnetic-Resonance Imaging.
Chu PC; Chai WY; Tsai CH; Kang ST; Yeh CK; Liu HL
Sci Rep; 2016 Sep; 6():33264. PubMed ID: 27630037
[TBL] [Abstract][Full Text] [Related]
31. Establishing sheep as an experimental species to validate ultrasound-mediated blood-brain barrier opening for potential therapeutic interventions.
Pelekanos M; Leinenga G; Odabaee M; Odabaee M; Saifzadeh S; Steck R; Götz J
Theranostics; 2018; 8(9):2583-2602. PubMed ID: 29721100
[No Abstract] [Full Text] [Related]
32. Unraveling the role of Intralipid in suppressing off-target delivery and augmenting the therapeutic effects of anticancer nanomedicines.
Islam R; Gao S; Islam W; Šubr V; Zhou JR; Yokomizo K; Etrych T; Maeda H; Fang J
Acta Biomater; 2021 May; 126():372-383. PubMed ID: 33774199
[TBL] [Abstract][Full Text] [Related]
33. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
34. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery.
Fan CH; Ting CY; Lin HJ; Wang CH; Liu HL; Yen TC; Yeh CK
Biomaterials; 2013 May; 34(14):3706-15. PubMed ID: 23433776
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound-induced blood-brain barrier opening for drug delivery.
Alonso A
Front Neurol Neurosci; 2015; 36():106-15. PubMed ID: 25531667
[TBL] [Abstract][Full Text] [Related]
36. Unilateral Opening of Rat Blood-Brain Barrier Assisted by Diagnostic Ultrasound Targeted Microbubbles Destruction.
Xu Y; Cui H; Zhu Q; Hua X; Xia H; Tan K; Gao Y; Zhao J; Liu Z
Biomed Res Int; 2016; 2016():4759750. PubMed ID: 27579317
[TBL] [Abstract][Full Text] [Related]
37. [Ultrasonic microbubbles for glioma-targeted drug delivery].
Chen LJ; Lu CT; Zhao YZ; Du LN; Jin YG
Yao Xue Xue Bao; 2015 Jan; 50(1):99-103. PubMed ID: 25924483
[TBL] [Abstract][Full Text] [Related]
38. Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence.
Duskey JT; Ottonelli I; Da Ros F; Vilella A; Zoli M; Kovachka S; Spyrakis F; Vandelli MA; Tosi G; Ruozi B
Nanomedicine; 2020 Aug; 28():102226. PubMed ID: 32479916
[TBL] [Abstract][Full Text] [Related]
39. Novel Treatment Approaches for Brain Tumour from a Blood-Brain Barrier Perspective.
Wu SK; Tsai CL; Hynynen K
Handb Exp Pharmacol; 2022; 273():351-364. PubMed ID: 33454856
[TBL] [Abstract][Full Text] [Related]
40. Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption.
Janowicz PW; Houston ZH; Bunt J; Fletcher NL; Bell CA; Cowin G; Howard CB; Taslima D; Westra van Holthe N; Prior A; Soh V; Ghosh S; Humphries J; Huda P; Mahler SM; Richards LJ; Thurecht KJ
Biomaterials; 2022 Apr; 283():121416. PubMed ID: 35217483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
